ATE320724T1 - Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung - Google Patents
Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichungInfo
- Publication number
- ATE320724T1 ATE320724T1 AT99204607T AT99204607T ATE320724T1 AT E320724 T1 ATE320724 T1 AT E320724T1 AT 99204607 T AT99204607 T AT 99204607T AT 99204607 T AT99204607 T AT 99204607T AT E320724 T1 ATE320724 T1 AT E320724T1
- Authority
- AT
- Austria
- Prior art keywords
- physical exercise
- oral administration
- during physical
- peptide material
- preparation containing
- Prior art date
Links
- 150000001720 carbohydrates Chemical class 0.000 title abstract 2
- 239000000463 material Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000002503 metabolic effect Effects 0.000 title 1
- 235000015097 nutrients Nutrition 0.000 title 1
- 239000013589 supplement Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000006362 insulin response pathway Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99204607A EP1112693B1 (de) | 1999-12-30 | 1999-12-30 | Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE320724T1 true ATE320724T1 (de) | 2006-04-15 |
Family
ID=8241130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99204607T ATE320724T1 (de) | 1999-12-30 | 1999-12-30 | Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung |
Country Status (4)
Country | Link |
---|---|
US (1) | US6713082B2 (de) |
EP (1) | EP1112693B1 (de) |
AT (1) | ATE320724T1 (de) |
DE (1) | DE69930464D1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
CZ20022927A3 (cs) * | 2000-02-01 | 2003-06-18 | Muscletech Research And Development Inc. | Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly |
EP1327390B1 (de) * | 2001-12-04 | 2008-01-09 | Kerry Group Services International Limited | Verfahren zur Herstellung von belüfteten kohlenhydrathaltigen Produkten |
GB0207830D0 (en) * | 2002-04-04 | 2002-05-15 | Mars Uk Ltd | Animal composition |
US7338675B2 (en) * | 2002-05-10 | 2008-03-04 | Tsi Health Sciences, Inc. | Fenugreek seed bio-active compositions and methods for extracting same |
US20050176827A1 (en) * | 2002-05-10 | 2005-08-11 | Lee Steve S. | Compositions and methods for glycogen synthesis |
JP2005538704A (ja) | 2002-07-01 | 2005-12-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 満腹誘導組成物 |
US7648957B2 (en) * | 2002-09-04 | 2010-01-19 | Dsm Ip Assets B.V. | Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
ATE349804T1 (de) | 2002-09-06 | 2007-01-15 | Ericsson Telefon Ab L M | Zusammengesetzter leistungsverstärker |
US20060171992A1 (en) * | 2002-12-20 | 2006-08-03 | Gerhardt Cinderella C | Blood glucose regulating composition |
US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
GB0313630D0 (en) * | 2003-06-12 | 2003-07-16 | Wwk Trust The | Compositions for the enhanced treatment of depression |
US7850989B2 (en) * | 2003-06-12 | 2010-12-14 | Provimi North America, Inc. | Critical care for neonatal calves |
JP2005289861A (ja) * | 2004-03-31 | 2005-10-20 | Meiji Seika Kaisha Ltd | グリコーゲンの貯蔵促進用の組成物 |
US20080317886A1 (en) * | 2005-11-03 | 2008-12-25 | Sparkman Dennis R | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness |
CA2649842C (en) * | 2006-04-21 | 2015-02-17 | Meiji Seika Kaisha, Ltd. | Composition containing peptide as active ingredient |
US20070280997A1 (en) * | 2006-05-31 | 2007-12-06 | Pacifichealth Laboratories, Inc. | Composition for enhancing muscle recovery |
GB0617182D0 (en) * | 2006-08-31 | 2006-10-11 | Glaxo Group Ltd | Novel use |
AU2007341981A1 (en) * | 2006-12-29 | 2008-07-10 | The Salk Institute For Biological Studies | Methods for enhancing exercise performance |
WO2008082577A2 (en) * | 2006-12-30 | 2008-07-10 | The Coca-Cola Company | A composition comprising saccharides and peptides and uses thereof |
EP1969950A1 (de) * | 2007-03-12 | 2008-09-17 | Cargill, Incorporated | Teilweise hydrolysiertes Getreideprotein |
FR2938733A1 (fr) * | 2008-11-21 | 2010-05-28 | Holymark | Composition administrable par voie orale,en particulier pour personne pratiquant une activite physique et complement alimentaire renfermant une telle composition |
US9131710B2 (en) | 2009-03-02 | 2015-09-15 | Roquette Freres | Vegetable milk granulated powder, process for producing vegetable milk, and uses thereof |
US8568743B2 (en) | 2009-04-29 | 2013-10-29 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
EP2327316B1 (de) * | 2009-11-29 | 2016-11-16 | Premier Nutrition Corporation | Verfahren zur steigerung der muskelproteinsynthese |
JP2013535984A (ja) | 2010-08-24 | 2013-09-19 | アボット・ラボラトリーズ | 官能特性を改善した栄養製品 |
US11235008B2 (en) * | 2011-03-31 | 2022-02-01 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
NZ711956A (en) | 2013-03-08 | 2018-06-29 | Axiom Foods Inc | Rice protein supplements |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3080234A (en) * | 1960-12-06 | 1963-03-05 | Pfizer & Co C | Method of improving the efficiency of amino acid diets |
US4042688A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of providing high-protein nutrition by the oral administration of a predigested protein composition |
JPH0647547B2 (ja) * | 1985-03-20 | 1994-06-22 | 大塚製薬株式会社 | 栄養補給飲食品 |
FI904074A0 (fi) * | 1989-08-28 | 1990-08-17 | Milupa Ag | Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk. |
ES2063882T5 (es) * | 1989-10-02 | 2001-12-01 | Novartis Nutrition Ag | Hidrolizados de proteinas. |
LU88371A1 (fr) * | 1993-07-12 | 1994-04-01 | Michel Urso Prof Medecin Et Ch | Acides aminés essentiels renforcés |
US5480865A (en) * | 1994-02-25 | 1996-01-02 | Parkinson's Charitable Trust | Nutritional composition |
MY115050A (en) * | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
AU2633997A (en) * | 1996-04-18 | 1997-11-12 | Md Foods A.M.B.A. | Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
US6051236A (en) * | 1998-11-12 | 2000-04-18 | Pacifichealth Laboratories, Inc. | Composition for optimizing muscle performance during exercise |
-
1999
- 1999-12-30 EP EP99204607A patent/EP1112693B1/de not_active Expired - Lifetime
- 1999-12-30 AT AT99204607T patent/ATE320724T1/de not_active IP Right Cessation
- 1999-12-30 DE DE69930464T patent/DE69930464D1/de not_active Expired - Lifetime
-
2000
- 2000-12-29 US US09/750,031 patent/US6713082B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1112693B1 (de) | 2006-03-22 |
US20010031729A1 (en) | 2001-10-18 |
DE69930464D1 (de) | 2006-05-11 |
EP1112693A1 (de) | 2001-07-04 |
US6713082B2 (en) | 2004-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE320724T1 (de) | Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung | |
EA200100088A1 (ru) | Готовая препаративная форма в виде микрочастиц для ингаляции | |
MY131810A (en) | Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes | |
AU2003273967A1 (en) | Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases | |
ATE185149T1 (de) | Immunogene verbindungen mit spezifischem anti- cytokin effekt, methode zur herstellung, pharmazeutische zusammensetzung und reaktionskit der diese enthält | |
IL147852A0 (en) | Chemokine receptor antagonists and pharmaceutical compositions containing the same | |
DE69928226D1 (de) | Chemokin rezeptor antagonisten und verwndung | |
EP1078636A4 (de) | Neue pharmazeutische zusammenstellung zur verwendung in notbehandlungen und dessen herstellungsverfahren | |
DE60003837D1 (de) | Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung | |
DK1401422T3 (da) | Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
KR900011784A (ko) | α, D-글루코푸라노오스 또는 α,D-알로푸라노오스 유도체와 중간체 및 그의 제조방법 | |
DE60041655D1 (de) | Auslösender rezeptor der an der natürlichen cytotoxizität der menschlichen natürlichen killerzellen (natural killer cells) beteiligt ist und antikörper die diesen rezeptor identifizieren | |
ATE77957T1 (de) | Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten. | |
WO2003045942A3 (en) | Chemokine receptor antagonists and methods of use thereof | |
MY136546A (en) | A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component | |
WO2002004487A3 (de) | Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen | |
BR0213823A (pt) | Método de administração de um peptìdeo timosina alfa 1 | |
EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
US5378823A (en) | Nucleic acids encoding type I interferon variants | |
WO2002068017A3 (en) | Method and composition for embalming | |
EP1688418A3 (de) | Chemokine rezeptor Antagonisten und methoden zu deren Anwendung | |
DE602004017512D1 (de) | Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält | |
EP1491192A4 (de) | Die biologische wirkung fördernde zusammensetzungen mit isoflavon-agklykon aus sojabohnenkeimen | |
Lamkin et al. | Purification and Partial Characterization of a M r 52,000 Glycoprotein from Human Cancer Ascites Fluid Which Stimulates Bone Resorption in Vitro | |
RU96104214A (ru) | Способ лечения транссудативных форм центральных хориоретинальных дистрофий |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |